Tectonic Therapeutic | AVRO - Net Income



Tectonic Therapeutic reported $-19980000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Adcock Ingram Holdings ZAR 389.71M 19.87M Dec/2024
Alnylam Pharmaceuticals USD -66277000 8.8M Jun/2025
Celltrion KRW 108.67B 127.98B Mar/2025
Cspc Pharmaceutical CNY 1.48B 927.97M Mar/2025
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Divis Laboratories Ltd 5.45B 1.17B Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
Kangmei Pharma CNY 8.4M 110.17K Jun/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Laboratorios Farma EUR 21.64M 70.9M Jun/2025
MacroGenics USD -36250000 20.83M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 304K 15.32M Dec/2024
Neuren Pharmaceuticals AUD 134.03M 126.01M Dec/2024
Organigram Holdings CAD -6290000 16.67M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Pharma Mar EUR 23.37M 27.32M Jun/2025
Qiagen NV USD 96.25M 5.49M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
Sarepta Therapeutics USD 196.89M 644.4M Jun/2025
Sartorius EUR 32.5M 15.9M Jun/2025
Sino Biopharmaceutical CNY 482.67M 2.53B Dec/2024
Takeda JPY 124.24B 227.4B Jun/2025
Tilray USD -85342000 46.18M Nov/2024
Zz Pientze Pharmaceu 442.53M 557.25M Jun/2025